TREATMENT OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME WITH TAMSULOSIN: A RANDOMIZED DOUBLE BLIND TRIAL
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most (eight) showed positive results, with significant differences vs placebo in NIH‐CPSI total, urinary symptom, pain, and/or QoL scores 54, 55, 56, 57, 59, 60, or in scores using other validated symptom scoring tools 58, 61.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 20
- McNaughton Collins, 1998, How common is prostatitis? A national survey of physician visits, J Urol, 159, 1224, 10.1016/S0022-5347(01)63564-X · DOI · Paper page
- McNaughton Collins, 2002, Prevalence and correlates of prostatitis in the health professionals follow-up study cohort, J Urol, 167, 1363, 10.1016/S0022-5347(05)65301-3 · DOI · Paper page
- Nickel, 1999, Prostatitis: evolving management strategies, Urol Clin North Am, 26, 737, 10.1016/S0094-0143(05)70215-9 · doi:10.1016/s0094-0143(05)70215-9
- Roberts, 1998, Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men, Urology, 51, 578, 10.1016/S0090-4295(98)00034-X · DOI · Paper page
- Lacquaniti, 1999, Terazosine and tamsulosin in non bacterial prostatitis: a randomized placebo-controlled study, Arch Ital Urol Androl, 71, 283
- de la Rosette, 1992, Research in ‘prostatitis syndromes’: the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities, Eur Urol, 22, 222, 10.1159/000474760 · doi:10.1159/000474760
- Neal, 1994, Use of terazosin in prostatodynia and validation of a symptom score questionnaire, Urology, 43, 460, 10.1016/0090-4295(94)90231-3 · doi:10.1016/0090-4295(94)90231-3
- Lepor, 1998, Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group, Urology, 51, 892, 10.1016/S0090-4295(98)00126-5 · DOI · Paper page
- Lepor, 1998, Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group, Urology, 51, 901, 10.1016/S0090-4295(98)00127-7 · DOI · Paper page
- Narayan, 2001, Long-term efficacy of tamsulosin: results of a 6-year experience, J Urol, 165, 381
- Yasukawa, 2001, Review of orthostatic tests on the safety of tamsulosin, a selective alpha1A-adrenergic receptor antagonist, shows lack of orthostatic hypotensive effects, J Int Med Res, 29, 236, 10.1177/147323000102900312 · DOI
- Propert, 2002, Design of a multi-center randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome, Urology, 59, 870, 10.1016/S0090-4295(02)01601-1 · doi:10.1016/s0090-4295(02)01601-1
- Meares, 1968, Bacteriologic localization patterns in bacterial prostatitis and urethritis, Invest Urol, 5, 492
- Litwin, 1999, The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure, J Urol, 162, 369, 10.1016/S0022-5347(05)68562-X · DOI · Paper page
- Nickel, 2003, A randomized, placebo-controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis, J Urol, 169, 1401, 10.1097/01.ju.0000054983.45096.16 · DOI · Paper page
- Ishigooka, 2002, Spinal substance P immunoreactivity is enhanced by acute chemical stimulation of the rat prostate, Urology, 59, 139, 10.1016/S0090-4295(01)01470-4 · doi:10.1016/s0090-4295(01)01470-4
- Lyseng-Williamson, 2002, Tamsulosin: an update of its role in the management of lower urinary tract symptoms, Drugs, 62, 135, 10.2165/00003495-200262010-00006 · doi:10.2165/00003495-200262010-00006
- Barbalias, 1998, Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics, J Urol, 159, 883, 10.1016/S0022-5347(01)63761-3 · doi:10.1016/s0022-5347(01)63761-3
- Cheah, 2003, Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial, J Urol, 169, 592, 10.1016/S0022-5347(05)63960-2 · doi:10.1016/s0022-5347(05)63960-2
- Mehik, 2003, Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized double-blind, placebo-controlled, pilot study, Urology, 62, 425, 10.1016/S0090-4295(03)00466-7 · DOI · Paper page
Cited by
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Borgert, B. J., Wallen, E. M., & Pham, M. N. (2025) · JAMA · doi:10.1001/jama.2025.11499 · Cited by 50
Metadata
- Authors
- NICKEL, J. C., NARAYAN, P., McKAY, J., & DOYLE, C.
- Affiliations
- From Queen’s University (JCN), Kingston, Ontario, Canada, North Florida Research Institute (PN), Gainesville, Florida, and Boehringer Ingelheim Pharmaceuticals, Inc. (JM, CD), Ridgefield, Connecticut
- Venue
- Journal of Urology
- Published
- 2004-04
- Volume
- 171
- Issue
- 4
- Pages
- 1594-1597
- ISSN
- 0022-5347
- 1527-3792
- Cited by
- 140
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TREATMENT OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME WITH TAMSULOSIN: A RANDOMIZED DOUBLE BLIND TRIAL. https://app.cochat.ai/papers/10.1097/01.ju.0000117811.40279.19
- The paper
- NICKEL, J. C., NARAYAN, P., McKAY, J., & DOYLE, C. (2004). TREATMENT OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME WITH TAMSULOSIN: A RANDOMIZED DOUBLE BLIND TRIAL. Journal of Urology. https://doi.org/10.1097/01.ju.0000117811.40279.19
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.